Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$925,418
-$2,096,972 QoQ
Shares Held
38,431
-64.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,369
of 2,812 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $668,956,159 across 9 Drug Manufacturers - General names. PFE ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
851,550 | $308,363,285 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,158,772 | $272,739,254 | |
| 3 | LLY |
ELI LILLY & Co
|
29,882 | $35,841,370 | |
| 4 | JNJ |
Johnson & Johnson
|
103,280 | $26,230,021 | |
| 5 | MRK |
Merck & Co., Inc.
|
113,061 | $14,528,338 | |
| 6 | ABBV |
AbbVie Inc.
|
40,476 | $10,185,380 | |
| 7 | PFE |
Pfizer Inc
This page
|
38,431 | $925,418 | |
| 8 | BIIB |
Biogen Inc.
|
338 | $73,028 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $925,418 | 38,431 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,022,390 | 107,635 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,415,490 | 56,847 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $301,351 | 11,827 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,718,979 | 70,915 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,059,703 | 120,746 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,755,586 | 141,560 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,082,710 | 141,075 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,479,419 | 88,614 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $938,893 | 33,834 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $658,369 | 22,868 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $316,939 | 9,555 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $30,220,356 | 740,695 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $40,411,604 | 788,673 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $33,577,048 | 767,300 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $43,814,912 | 835,684 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,407,305 | 46,500 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,672,650 | 113,000 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,283,796 | 99,600 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $2,720,259 | 73,900 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,712,127 | 73,900 | Shares | Defined | 2020-11-16 | |
| 2020-03-31 | $2,937,596 | 90,000 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||